| 1 (46) | Boehringer Ingelheim * | MUL |  |
| 2 (53) | Samsung Corp * | MUL | |
| 3 (54) | Pfizer * | MUL | |
| 4 (69) | Johnson & Johnson * | MUL | |
| 4 (69) | AstraZeneca * | MUL | |
| 6 (73) | Novartis * | MUL | |
| 7 (80) | Janssen Biotech Inc | USA | |
| 8 (83) | Pfizer Inc, United States | USA | |
| 9 (84) | F Hoffmann-La Roche * | MUL | |
| 10 (90) | Eli Lilly * | MUL | |
| 11 (91) | Janssen | MUL | |
| 12 (92) | Eli Lilly and Company, United States | USA | |
| 13 (103) | Novartis, Switzerland | CHE | |
| 14 (119) | Hoffmann-La Roche Ltd, United States | USA | |
| 15 (127) | Genentech Inc | USA | |
| 16 (131) | Novartis Pharmaceuticals, United States | USA | |
| 17 (133) | GlaxoSmithKline * | MUL | |
| 18 (152) | UCB Pharma SA * | MUL | |
| 19 (162) | GlaxoSmithKline, United Kingdom | GBR | |
| 20 (169) | AstraZeneca, United States | USA | |
| 21 (197) | Bristol-Myers Squibb Company, United States | USA | |
| 22 (228) | Bristol-Myers Squibb Company * | MUL | |
| 23 (245) | GlaxoSmithKline, United States | USA | |
| 24 (259) | Amgen * | MUL | |
| 25 (313) | AbbVie * | MUL | |
| 26 (315) | AbbVie Inc, United States | USA | |
| 27 (325) | Amgen, USA | USA | |
| 28 (370) | Merck * | MUL | |
| 29 (497) | Ormat Technologies Inc * | MUL | |
| 29 (497) | Ormat Technologies, United States | USA | |
|
